Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analysts give Acadia an average recommendation of "Hold" based on 16 firms (2 sell, 7 hold, 7 buy) with a one‑year consensus price target of about $21.15.
• Acadia beat quarterly estimates (EPS $0.07 vs. $0.03; revenue $821.5M vs. $800.1M), reported revenue up 6.1% year‑over‑year, and set FY2026 guidance of $1.30–$1.55 EPS and Q1 2026 guidance of $0.25–$0.30.
• Several banks raised targets recently (UBS to $27 buy, RBC to $28 outperform, Barclays to $20 equal weight), while the stock trades around $26.61 with a market cap of $2.45B and a negative trailing P/E of -2.18, signaling mixed sentiment and valuation dynamics.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has earned an average recommendation of "Hold" from the sixteen research firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $21.1538.

Several analysts recently issued reports on the company. Barclays raised their target price on Acadia Healthcare from $14.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Tuesday, March 3rd. UBS Group upped their price target on Acadia Healthcare from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Jefferies Financial Group cut Acadia Healthcare to a "hold" rating in a research note on Thursday, January 22nd. Finally, Royal Bank Of Canada upped their target price on Acadia Healthcare from $17.00 to $28.00 and gave the company an "outperform" rating in a report on Thursday, February 26th.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC boosted its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN raised its stake in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock worth $32,000 after buying an additional 1,510 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in Acadia Healthcare in the fourth quarter worth about $52,000. Hantz Financial Services Inc. lifted its holdings in Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company's stock worth $54,000 after buying an additional 1,822 shares during the period. Finally, GAMMA Investing LLC boosted its position in Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company's stock valued at $69,000 after acquiring an additional 2,698 shares in the last quarter.

Acadia Healthcare Trading Up 0.2%

Shares of ACHC stock opened at $26.61 on Thursday. The business has a 50-day moving average price of $21.78 and a two-hundred day moving average price of $19.01. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $28.48. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. The firm has a market cap of $2.45 billion, a P/E ratio of -2.18, a price-to-earnings-growth ratio of 8.97 and a beta of 0.71.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. During the same period last year, the firm posted $0.64 earnings per share. The business's revenue was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Equities analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.